In line with the first interim report from the DELCODE study based on a smaller sample [28], we found that SCD participants had lower age-adjusted CSF-Aß42 levels and lower CSF-Aß42/Tau ratios than HC, while the total Tau level and the p-Tau-181 level did not differ between groups. This evidence concerns the gene MAPT and Schnyder corneal dystrophy.